These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12163165)

  • 1. Inhibition of hepatitis C virus NS3 protease by peptides derived from complementarity-determining regions (CDRs) of the monoclonal antibody 8D4: tolerance of a CDR peptide to conformational changes of a target.
    Tsumoto K; Misawa S; Ohba Y; Ueno T; Hayashi H; Kasai N; Watanabe H; Asano R; Kumagai I
    FEBS Lett; 2002 Aug; 525(1-3):77-82. PubMed ID: 12163165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.
    Ueno T; Misawa S; Ohba Y; Matsumoto M; Mizunuma M; Kasai N; Tsumoto K; Kumagai I; Hayashi H
    J Virol; 2000 Jul; 74(14):6300-8. PubMed ID: 10864639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
    Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
    Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
    Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
    Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
    Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
    Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
    Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
    Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibitors of hepatitis C virus NS3 protease.
    Portal-Núñez S; González-Navarro CJ; García-Delgado M; Vizmanos JL; Lasarte JJ; Borrás-Cuesta F
    Antivir Chem Chemother; 2003 Sep; 14(5):225-33. PubMed ID: 14694985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and functional expression of a constitutively active single-chain NS4A-NS3 proteinase.
    Pasquo A; Nardi MC; Dimasi N; Tomei L; Steinkühler C; Delmastro P; Tramontano A; De Francesco R
    Fold Des; 1998; 3(6):433-41. PubMed ID: 9889156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1.
    Feng Y; Chung D; Garrard L; McEnroe G; Lim D; Scardina J; McFadden K; Guzzetta A; Lam A; Abraham J; Liu D; Endemann G
    J Biol Chem; 1998 Mar; 273(10):5625-30. PubMed ID: 9488691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.
    Tomei L; Failla C; Vitale RL; Bianchi E; De Francesco R
    J Gen Virol; 1996 May; 77 ( Pt 5)():1065-70. PubMed ID: 8609472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.
    Bianchi E; Urbani A; Biasiol G; Brunetti M; Pessi A; De Francesco R; Steinkühler C
    Biochemistry; 1997 Jun; 36(25):7890-7. PubMed ID: 9201934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.
    Bianchi E; Orrù S; Dal Piaz F; Ingenito R; Casbarra A; Biasiol G; Koch U; Pucci P; Pessi A
    Biochemistry; 1999 Oct; 38(42):13844-52. PubMed ID: 10529230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.
    Dahl G; Arenas OG; Danielson UH
    Biochemistry; 2009 Dec; 48(48):11592-602. PubMed ID: 19839643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.